Capital Expenditures for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current capital expenditures (TTM) is $524.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$524.00M
YoY change
+24.0%
5Y CAGR
+4.7%
Peak year (1999)
$1.10B
Cumulative capital expenditures
$8.31B
CapEx history chart for Quest Diagnostics (DGX) from 1996 to 2025
CapEx history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $527.00M | +24.0% | ||
| 2024 | $425.00M | +4.2% | ||
| 2023 | $408.00M | +1.0% | ||
| 2022 | $404.00M | +0.2% | ||
| 2021 | $403.00M | -3.6% | ||
| 2020 | $418.00M | +4.5% | ||
| 2019 | $400.00M | +4.4% | ||
| 2018 | $383.00M | +52.0% | ||
| 2017 | $252.00M | -14.0% | ||
| 2016 | $293.00M | +11.4% | ||
| 2015 | $263.00M | -14.6% | ||
| 2014 | $308.00M | +33.3% | ||
| 2013 | $231.00M | +26.8% | ||
| 2012 | $182.20M | +12.8% | ||
| 2011 | $161.50M | -21.4% | ||
| 2010 | $205.40M | +23.1% | ||
| 2009 | $166.90M | -21.5% | ||
| 2008 | $212.70M | -2.9% | ||
| 2007 | $219.10M | +13.3% | ||
| 2006 | $193.42M | -13.8% | ||
| 2005 | $224.27M | +27.3% | ||
| 2004 | $176.13M | +0.8% | ||
| 2003 | $174.64M | +12.5% | ||
| 2002 | $155.20M | +4.2% | ||
| 2001 | $148.99M | +27.9% | ||
| 2000 | $116.45M | -89.4% | ||
| 1999 | $1.10B | +2618.5% | ||
| 1998 | $40.50M | -13.5% | ||
| 1997 | $46.80M | -33.5% | ||
| 1996 | $70.40M | — |
CapEx values are taken from Quest Diagnostics's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Quest Diagnostics (DGX) most recent annual capital expenditures stands at $527.00M (2025) – grew 24.0% year-over-year.
Over 2020–2025 (5 years), Quest Diagnostics capital expenditures expanded at a +4.7% compound annual rate, sustaining 4 straight years of year-over-year growth.
Quest Diagnostics capital expenditures plunged from $1.10B in 1999 to $527.00M in 2025, a 52.1% drawdown.
Across the available history, capital expenditures reached its high of $1.10B in 1999 and its low of $40.50M in 1998.
Within Healthcare, Quest Diagnostics (DGX) ranks 9th among 8 peers we track. The peer median for capital expenditures is $3.87B.
Quest Diagnostics Capital Expenditures by Year
Quest Diagnostics Capital Expenditures 2025: $527.00M
Quest Diagnostics capital expenditures in 2025 was $527.00M, grew 24.0% from 2024.
Quest Diagnostics Capital Expenditures 2024: $425.00M
Quest Diagnostics capital expenditures in 2024 was $425.00M, edged up 4.2% from 2023.
Quest Diagnostics Capital Expenditures 2023: $408.00M
Quest Diagnostics capital expenditures in 2023 was $408.00M, edged up 1.0% from 2022.
Quest Diagnostics Capital Expenditures 2022: $404.00M
Quest Diagnostics capital expenditures in 2022 was $404.00M, edged up 0.2% from 2021.
Quest Diagnostics Capital Expenditures 2021: $403.00M
Quest Diagnostics capital expenditures in 2021 was $403.00M.
See more financial history for Quest Diagnostics (DGX).
Sector peers — CapEx
Companies in the same sector as Quest Diagnostics, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's capital expenditures?
- Latest reported capital expenditures for Quest Diagnostics (DGX) is $524.00M (period ending March 31, 2026).
How has Quest Diagnostics capital expenditures changed year-over-year?
- Quest Diagnostics (DGX) capital expenditures changed +24.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics capital expenditures?
- Quest Diagnostics (DGX) capital expenditures compound annual growth rate is +4.7% over the most recent 5 years available.
When did Quest Diagnostics capital expenditures hit its highest annual value?
- Quest Diagnostics capital expenditures reached its highest annual value of $1.10B in 1999.
What was Quest Diagnostics capital expenditures in 2024?
- Quest Diagnostics (DGX) capital expenditures in 2024 was $425.00M.
What was Quest Diagnostics capital expenditures in 2025?
- Quest Diagnostics (DGX) capital expenditures in 2025 was $527.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.